Effect of beta-blockers on the mortality of Japanese patients with myocardial infarction

International Journal of Cardiology

Volumn 108, Issue 3, 2006, Pages 309-313

  Yamada, Koichi ^a   Tsuji, Hisako ^b   Tokunaga, Satoshi ^a   Kurimoto, Koji ^a   Maeba, Hirofumi ^a   Matsuhisa, Seiji ^a   Inami, Norihito ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Health Examination Center of Moriguchi City   (Japan)

Author keywords

Beta blockers; Japanese; Mortality; Myocardial infarction

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY SPASM; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG EFFECT; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REPERFUSION; STATISTICAL ANALYSIS; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33644755574     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.015     Document Type: Article

References (30)

1. Beta-blocker Heart Attack Study Group The beta-blocker heart attack trial JAMA 246 1981 2073 2074
2. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
3. A. Hjalmarson, D. Elmfeldt, J. Herlitz, S. Holmberg, I. Malek, and G. Nyberg Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial Lancet 2 1981 823 827
4. A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results JAMA 247 1982 1707 1714
5. A multicenter study on timolol in secondary prevention after myocardial infarction Acta Med Scand Suppl 674 1983 1 129
6. T.R. Pedersen The Norwegian multicenter study of timolol after myocardial infarction Circulation 67 1983 I49 I53
7. J. Herlitz, D. Elmfeldt, S. Holmberg, I. Malek, G. Nyberg, and K. Pennert Goteborg metoprolol trial: mortality and causes of death Am J Cardiol 53 1984 9D 14D
8. The MIAMI Trial Research Group Metoprolol in acute myocardial infarction: mortality Am J Cardiol 56 1985 15G 22G
9. The MIAMI Trial Research Group Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial Eur Heart J 6 1985 199 226
10. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
11. A.W. Chan, M.J. Quinn, D.L. Bhatt, D.P. Chew, D.J. Moliterno, and E.J. Topol Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention J Am Coll Cardiol 40 2002 669 675
12. S. Yusuf, J. Wittes, and L. Friedman Overview of results of randomized clinical trials in heart disease: I. Treatments following myocardial infarction JAMA 260 1988 2088 2093
13. M.J. Kendall, K.P. Lynch, A. Hjalmarson, and J. Kjekshus Beta-blockers and sudden cardiac death Ann Intern Med 123 1995 358 367
14. J.F. Beltrame, S. Sasayama, and A. Maseri Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients J Am Coll Cardiol 33 1999 1442 1452
15. C. Pristipino, J.F. Beltrame, M.L. Finocchiaro, R. Hattori, M. Jujita, and R. Mongiardo Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction Circulation 101 2000 1102 1108
16. H. Yasue, M. Touyama, M. Shimamoto, H. Katoh, and S. Tanaka Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina Circulation 50 1974 534 539
17. H. Yasue, M. Touyama, H. Kato, S. Tanaka, and F. Akiyama Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography Am Heart J 91 1976 148 155
18. D.R. Ricci, A.E. Orlick, P.R. Cipriano, D.F. Guthaner, and D.C. Harriso Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram Am J Cardiol 43 1979 1073 1079
19. M.D. Winniford, N. Filipchuk, and L.D. Hillis Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial Circulation 67 1983 1185 1188
20. D.G. Julian Is the use of beta blockade contraindicated in the patient with coronary spasm? Circulation 67 1983 I92 I93
21. R.M. Robertson, A.J. Wood, W.K. Vaughn, and D. Robertson Exacerbation of vasotonic angina pectoris by propranolol Circulation 65 1982 281 285
22. P.Y. Tilmant, J.M. Lablanche, F.A. Thieuleux, B.A. Dupuis, and M.E. Bertrand Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem Am J Cardiol 52 1983 230 233
23. J.N. Nanas, R.B. Sutton, N. Alazraki, and T.J. Tsagaris Acute myocardial infarction in post infarct patient possibly through beta blocker-induced coronary artery spasm Am Heart J 113 1987 388 391
24. H. Nielsen, H. Egeblad, S.A. Mortensen, and E. Sandoe Observations on increased susceptibility to coronary artery vasospasm during beta blockade Am Heart J 114 1987 192 194
25. A. Maseri, G. Davies, D. Hackett, and J.C. Kaski Coronary artery spasm and vasoconstriction. The case for a distinction Circulation 81 1990 1983 1991
26. S.S. Anand, S. Ounpuu, and S. Yusuf Evidence-based cardiology 2nd ed. Ethnicity and cardiovascular disease 2003 BMJ Books London 259 278
27. K. Ishikawa, M. Miyataka, K. Kanamasa, T. Hayashi, T. Takenaka, and T. Inoki Beta-blockers reduce the incidence of cardiac events in post-myocardial infarction patients Jpn Heart J 41 2000 279 294
28. K. Ishikawa, M. Miyataka, K. Kanamasa, T. Hayashi, T. Takenaka, and T. Inoki Retrospective analysis showing less cardiac events in post-myocardial infarction patients treated with metoprolol. Secondary Prevention Group Jpn Circ J 64 2000 358 364
29. J.E. Madias The long-term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina Clin Cardiol 9 1986 277 284
30. D. Hasdai, A. Lerman, D.E. Grill, C.S. Rihal, and D.R. Holmes Jr. Medical therapy after successful percutaneous coronary revascularization Ann Intern Med 130 1999 108 115